Crossref journal-article
American Society for Microbiology
Antimicrobial Agents and Chemotherapy (235)
Abstract

In a double-blind, placebo-controlled study, self-administered intranasal human interferon alpha A produced by recombinant DNA technology was given both before and after virus challenge with a respiratory coronavirus. The incidence of colds, the severity of symptoms and signs, and virus replication were all reduced in subjects receiving interferon as compared with those given placebo.

Bibliography

Higgins, P. G., Phillpotts, R. J., Scott, G. M., Wallace, J., Bernhardt, L. L., & Tyrrell, D. A. (1983). Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. Antimicrobial Agents and Chemotherapy, 24(5), 713–715.

Authors 6
  1. P G Higgins (first)
  2. R J Phillpotts (additional)
  3. G M Scott (additional)
  4. J Wallace (additional)
  5. L L Bernhardt (additional)
  6. D A Tyrrell (additional)
References 0 Referenced 71

None

Dates
Type When
Created 13 years, 2 months ago (June 27, 2012, 8:03 p.m.)
Deposited 3 years, 6 months ago (Feb. 21, 2022, 9:28 a.m.)
Indexed 2 months, 3 weeks ago (June 11, 2025, 7:47 p.m.)
Issued 41 years, 10 months ago (Nov. 1, 1983)
Published 41 years, 10 months ago (Nov. 1, 1983)
Published Print 41 years, 10 months ago (Nov. 1, 1983)
Funders 0

None

@article{Higgins_1983, title={Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers}, volume={24}, ISSN={1098-6596}, url={http://dx.doi.org/10.1128/aac.24.5.713}, DOI={10.1128/aac.24.5.713}, number={5}, journal={Antimicrobial Agents and Chemotherapy}, publisher={American Society for Microbiology}, author={Higgins, P G and Phillpotts, R J and Scott, G M and Wallace, J and Bernhardt, L L and Tyrrell, D A}, year={1983}, month=nov, pages={713–715} }